A. Cavalli

发表

Interindividual and Intra-Individual Variabilities of Darunavir and Ritonavir Plasma Trough Concentrations in Multidrug Experienced HIV Patients Receiving Salvage Regimens

D. Francisci, M. Regazzi, P. Villani, 2013, Therapeutic drug monitoring.

Long-lasting memory T cell responses following self-limited acute hepatitis B.

F. Chisari, A. Bertoletti, M. Levrero, 1996, The Journal of clinical investigation.

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

D. Francisci, L. Monno, R. Bucciardini, 2012, The Journal of antimicrobial chemotherapy.

Immune pathogenesis of hepatitis B.

A. Bertoletti, G. Missale, C. Ferrari, 1992, Archives of virology. Supplementum.

Immunopathogenesis of hepatitis C virus infection.

C. Ferrari, R. Bertoni, A. Penna, 1999, Journal of hepatology.

Markers of microbial translocation during pregnancy: differences among HIV+ women of African and European provenance.

M. Floridia, S. Baroncelli, M. Pirillo, 2020, Journal of infection in developing countries.

Lamivudine treatment can overcome cytotoxic T‐cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy

G. Ogg, A. Bertoletti, C. Ferrari, 2001, Hepatology.

Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens

B. Moss, F. Chisari, A. Bertoletti, 1992, Journal of virology.

Characterization of Hepatitis B Virus (HBV)-Speciﬁc T-Cell Dysfunction in Chronic HBV Infection (cid:1)

A. Bertoletti, G. Missale, C. Ferrari, 2007 .

Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections.

A. Bertoletti, G. Missale, P. Scognamiglio, 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

A. Bertoletti, P. Scognamiglio, C. Ferrari, 1998, The Journal of clinical investigation.

Predominant T‐helper 1 cytokine profile of hepatitis B virus nucleocapsid‐specific T cells in acute self‐limited hepatitis B

A. Bertoletti, M. D’Elios, M. D'Amato, 1997, Hepatology.

DPB1*5901a: a novel HLA-DPB1 allele from a Caucasian family with insulin-dependent diabetes mellitus.

H. Erlich, J. Noble, A. Cavalli, 1996, Tissue antigens.

Four new DP alleles identified in a study of 500 unrelated bone marrow donor-recipient pairs.

A. Begovich, H. Noreen, T. Williams, 1999, Tissue antigens.

Three new DP alleles identified in sub-Saharan Africa: DPB1*7401, DPA1*02013, and DPA1*0302.

A. Begovich, R. Lucius, V. Titanji, 1998, Tissue antigens.

Two new DPB1 alleles identified in a study of the genetics of susceptibility to pauciarticular juvenile rheumatoid arthritis.

A. Begovich, D. McCurdy, A. Cavalli, 1997, Tissue antigens.

Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen.

A. Bertoletti, T. Neri, C. Ferrari, 1992, Gastroenterology.

The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

A. Bertoletti, C. Ferrari, A. Penna, 1989, The Journal of clinical investigation.

Autopresentation of hepatitis B virus envelope antigens by T cells

A. Bertoletti, G. Pasetti, C. Ferrari, 1992, Journal of virology.

Cell-mediated Immune Response in Hepatitis C Virus (HCV) Infection: Are Different Strategies Adopted by HCV and Hepatitis B Virus to Persist?

A. Bertoletti, G. Missale, C. Ferrari, 1996 .

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

M. Massari, G. Missale, C. Ferrari, 2012, Gastroenterology.

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.

F. Chisari, A. Bertoletti, G. Missale, 1991, The Journal of clinical investigation.

Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.

A Valli, A. Bertoletti, M. Petit, 1990, Journal of immunology.

Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection

A. Bertoletti, G. Missale, C. Ferrari, 2007, Journal of Virology.

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

A. Bertoletti, G. Missale, C. Ferrari, 2003, Journal of hepatology.

Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection

A. Bertoletti, G. Missale, C. Ferrari, 2007, Journal of Cancer Research and Clinical Oncology.

Fine specificity of the human T cell response to hepatitis B virus core antigen.

F. Chisari, A. Bertoletti, G. Missale, 1992, Archives of virology. Supplementum.

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.

C. Mancini, F. Aversa, G. Donofrio, 2016, Blood.

Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules

R. Rappuoli, A. Mantovani, L. Varani, 2021, Nature Immunology.

Intrahepatic and circulating HLA class II–restricted, hepatitis C virus–specific T cells: Functional characterization in patients with chronic hepatitis C

G. Missale, P. Zanelli, C. Ferrari, 2002, Hepatology.

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1

M. Hust, H. Marcotte, Z. Chavoshzadeh, 2023, The Lancet Regional Health - Western Pacific.

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.

F. Chisari, A. Bertoletti, G. Missale, 1991, The Journal of clinical investigation.

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

M. Massari, G. Missale, C. Ferrari, 2012, Gastroenterology.